Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 79 results found. Search for [ russia corona vaccine ]

Results 1 to 21 of 79
BusinessToday.In
November 30, 2020
There are only five companies that have given preliminary data about how effective their vaccines could be to fight against coronavirus. These five companies include Pfizer-BioTech, Moderna Inc, Oxford University-AstraZeneca Plc, and Gamaleya Institute


BusinessToday.In
New Delhi, November 25, 2020
Two-wheeler exports to witness stable growth in second half of FY21-22; Corporate debt reduces by Rs 68,000 cr in H1FY21; RIL, IOC, BPCL ease burden; India bans 43 Chinese mobile apps, under Section 69A of the Information Technology Act. Watch this and more on News Blast.Also Read: Relief for depositors! Lakshmi Vilas Bank's withdrawal restrictions lifted


PB Jayakumar & Joe C Mathew
New Delhi, November 25, 2020
A blow-by-blow account of how Indian vaccines are being readied


BusinessToday.In
November 24, 2020
Russia's Sputnik V coronavirus vaccine has shown 95% efficacy, according to a second interim analysis of its human clinical trial data


BusinessToday.In
November 23, 2020
It has been found that one of the vaccine's dosing regimens may be around 90% effective and if this dosing regime is used, more people could be vaccinated with planned vaccine supply, says AstraZeneca


Rajeev Dubey
November 20, 2020
Emboldened, firms indulge in a game of one-upmanship based on alarmingly low number of trials. Sputnik had been tried on only 20 patients before Gamaleya made the claim; Pfizer 120 and Moderna 95


PTI
November 15, 2020
College principal R B Kamal said the effect of the vaccine on the volunteers will be studied for seven months after the same is administered once, twice or thrice within an interval of 21 day


BusinessToday.In
November 10, 2020
As coronavirus cases rise all over the world, Brazil continues to remain the third most affected country globally


BusinessToday.In
October 30, 2020
Coronavirus vaccine update: Staff from eight of the 25 Moscow clinics where the trials are taking place said that the vaccination of new participants in the Phase 3 of trials have been temporarily paused


Associated Press
October 25, 2020
Coronavirus vaccine update: Testing of the AstraZeneca vaccine, developed with Oxford University, has already resumed in the United Kingdom, Brazil, South Africa and Japan


Reuters
October 24, 2020
Tedros said too many countries were now seeing an exponential increase in infections, \"and that is now leading to hospitals and intensive care units running close or above capacity -- and we're still only in October\".


BusinessToday.In
October 22, 2020
Bharat Biotech Phase 3 trials: The volunteers would be given two doses of the experimental vaccine in a gap of 28 days


BusinessToday.In
October 19, 2020
Presently, there are around 40 different coronavirus vaccines in various stages of human clinical trials, comprising one being developed by Oxford University and AstraZeneca, which is already in an advanced stage of testing


BusinessToday.In
New Delhi, October 19, 2020
Retail cheque payments fall to 2.96% in FY20 amid digitisation push: RBI; Develop COVID vaccine delivery system akin to polls, disaster management: PM Modi; Digital media, news agencies given a year to comply with 26% FDI cap. Watch this and more news on News Blast.Also Read: Gold price trades flat for second day; silver rates at Rs 61,500


BusinessToday.In
New Delhi, October 15, 2020
As part of its effort to fast-track COVID-19 vaccine development, Hyderabad-based Bharat Biotech has cut the size of Phase 2 clinical trials of its indigenous coronavirus vaccine Covaxin by half; Bicycle sales in India have grown by over two-folds in the last five months as people are opting for this cheapest mode of transport to cover short to medium distance; Russia on Wednesday announced that it has granted regulatory approval to another COVID-19 vaccine named EpiVacCorona. Watch this and more on News Blast.Also Read: Need to develop more disease-specific health insurance policies: IRDAI


Associated Press
October 15, 2020
We now need to increase production of the first vaccine and the second vaccine, Russian President Vladimir Putin said, adding that the priority was to supply the Russian market with the vaccines


BusinessToday.In
October 11, 2020
Coronavirus update: The Health Ministry said that five states have the maximum caseload in the country -- Maharashtra, Karnataka, Kerala, Andhra Pradesh and Tamil Nadu


Associated Press
October 10, 2020
Coronavirus pandemic: Record high daily infections in several eastern European countries and sharp rebounds in the hard-hit west have made clear that Europe never really crushed the COVID-19 curve as hoped


BusinessToday.In
October 10, 2020
China was the first to report the outbreak, identified the pathogen and shared the genome sequence with the world, said Chinese Foreign Ministry spokesperson


BusinessToday.In
New Delhi, October 9, 2020
India's drug regulator has declined a proposal from Hyderabad-based Dr Reddy's Laboratories Ltd to carry out a large study in the country to evaluate Russia's Sputnik-V coronavirus vaccine. The recommendations by an expert panel of the Central Drugs Standard Control Organisation (CDSCO) noted that safety and immunogenicity data from early-stage studies being conducted overseas is small, with no inputs available on Indian participants. Watch the video for more.Also Read: COVID-19 vaccine: Dr Reddy's asked to resubmit application for conducting trials of Sputnik V


PAGES 1 OF 4  1234